ClinicalTrialsFinder

Myelo Dysplastic Syndrome Clinical Trials in Clermont-Ferrand

1 recruitingClermont-Ferrand, France

Showing 1–1 of 1 trials

Recruiting
Phase 2

Momelotinib in VEXAS Syndrome

VEXAS SyndomeMyelo Dysplastic Syndrome
Groupe Francophone des Myelodysplasies57 enrolled11 locationsNCT07098936